Nabriva Therapeutics Plc Overview

Nabriva Therapeutics Plc EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NBRV.

Quarterly EBIT

-$8.48M

↑ 26.67% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$52.41M

↓ 13.64% YoY

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin